Observational Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. May 26, 2024; 16(5): 282-292
Published online May 26, 2024. doi: 10.4330/wjc.v16.i5.282
Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan
Rubina Rauf, Muhammad Ismail Soomro, Muhamman Nauman Khan, Mukesh Kumar, Najia Aslam Soomro, Khawar Abbas Kazmi
Rubina Rauf, Muhammad Ismail Soomro, Khawar Abbas Kazmi, Department of Preventive Cardiology, National Institute of Cardiovascular Diseases, Karachi 75510, Pakistan
Muhamman Nauman Khan, Mukesh Kumar, Department of Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi 75510, Pakistan
Najia Aslam Soomro, Department of Cardiology, Liaquat National Hospital, Karachi 74800, Pakistan
Author contributions: Rauf R, Soomro MI, Khan MN, Kumar M, Soomro NA and Kazmi KA contributed to the concept, design of the study, the collection, analysis, interpretation of data and the drafting of the manuscript; Rauf R, Soomro MI, Kumar M and Kazmi KA critically analyzed all content. All authors have read and approved the manuscript.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the National Institute of Cardiovascular Diseases (NICVD), Karachi (No. ERC-26/2022).
Informed consent statement: Written consent was waived by the institution review board due to observational nature of the study, hence, verbal informed consent was obtained from all the patients.
Conflict-of-interest statement: All authors have no conflict of interest to disclose.
Data sharing statement: Data and material will be available upon request.
STROBE statement: The authors have read the STROBE Statement – checklist of items, and the manuscript was prepared and revised according to the STROBE Statement – checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rubina Rauf, FCPS, Assistant Professor, Department of Preventive Cardiology, National Institute of Cardiovascular Diseases, Rafiqui (H.J.) Shaheed Road, Karachi 75510, Pakistan. drrubinarauf@gmail.com
Received: December 23, 2023
Revised: April 1, 2024
Accepted: April 22, 2024
Published online: May 26, 2024
Processing time: 152 Days and 7.5 Hours
Core Tip

Core Tip: Lipid treatment practices and levels in post-acute myocardial infarction (AMI) patients, which are crucial for secondary prevention. This study examined lipid treatment practices and levels in post-AMI patients at a Pakistani tertiary care hospital. Among 195 patients, only 13.8% underwent lipid profile testing post-AMI. While 88.7% received recommended statin therapy, only 11.5% achieved target low-density lipoprotein cholesterol levels. Non-compliance with statin therapy correlated with higher re-admission and subsequent AMI rates. The findings underscore the importance of optimizing lipid assessment practices to reduce the risk of recurrent events in post-AMI patients.